W
Waterstone Pharmaceuticals
Engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases
About Waterstone Pharmaceuticals
Waterstone Pharma is an international biopharmaceutical company primarily operating in China, dedicated to the discovery, development, and commercialization of innovative drugs targeting significant unmet medical needs, particularly in liver and gastrointestinal diseases. The company serves a global market and is backed by venture capital investments from renowned firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps. Waterstone Pharma has established fully integrated capabilities spanning from research and development (R&D) to active pharmaceutical ingredient (API) and finished drug product manufacturing. The company generates revenue through the commercialization of its therapeutic products, including over forty marketed drugs in China, and is actively involved in clinical trials and preclinical stage antiviral research. Waterstone's strong management team boasts cross-border experience and expertise in drug discovery, regulatory affairs, and good manufacturing practices (GMP), ensuring a robust pipeline of novel therapeutics.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Sep 2020 | $61M | $244M | State Development & Investment Corporation (SDIC) | — |
| DEBTDebt | Sep 2012 | $19M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Waterstone Pharmaceuticals is 930 monthly website visits, up 52.5% over the last three months. Waterstone Pharmaceuticals's team grew 5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Waterstone Pharmaceuticals in the Carmel ecosystem
The Waterstone Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
State Development & Investment Corporation (SDIC)
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Waterstone Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Waterstone Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










